Equity News Results

  • Dow on Track to Wrap Up Worst Month Since March

    U.S. stocks fell Friday, with the Dow Jones Industrial Average on track to close out its worst week and month since March. It has already shed more than 7% this week, putting it on track for its worst weekly performance since the height of the pandemic-induced market tumult. The S&P 500 fell 1.9%, pulled down by declines in all 11 sectors.

  • US STOCKS-Tech stocks knock down Wall St as coronavirus cases spiral

    * Twitter slumps as user growth disappoints. * Apple (AAPL), Amazon (AMZN), Facebook (FB) drop after results. * Alphabet rises as businesses resume ad spending. * Indexes down: Dow 1.6%, S&P 1.8%, Nasdaq 2.7% By Medha Singh and Shivani Kumaresan.

  • Dow on Track to Wrap Up Worst Month Since March

    U.S. stocks fell Friday, with the Dow Jones Industrial Average on track to close out its worst week and month since March, following a sharp selloff in big technology stocks. It has already shed more than 7% this week, putting it on track for its worst weekly performance since the height of the market tumult. The S&P 500 fell 1.5% and tech-heavy Nasdaq Composite was down 2.3%.

  • Dow on Track to Wrap Up Worst Month Since March

    U.S. stocks fell Friday, with the Dow Jones Industrial Average on track to close out its worst week and month since March, following a sharp selloff in big technology stocks. It has already shed more than 6% this week, putting it on track for its worst weekly performance since the height of the market tumult. The S&P 500 fell 0.9% and tech-heavy Nasdaq Composite was down 1.6%.

  • US STOCKS-Wall St slumps as tech stocks slide, COVID cases jump

    * Twitter slumps as user growth disappoints. * Under Armour (UAA) climbs as revenue forecast exceeds expectations. * Apple (AAPL), Amazon (AMZN), Facebook (FB) drop after results. * Alphabet rises as businesses resume ad spending. * Indexes down: Dow 0.9%, S&P 1%, Nasdaq 1.7% By Medha Singh and Shivani Kumaresan.

  • U.S. consumer spending beats forecasts; worries over decreasing government money

    * Consumer spending increases 1.4% in September. * Personal income rebounds 0.9%; savings rate dips to 14.3% * Core PCE price index rises 0.2%; up 1.5% year-on-year. By Lucia Mutikani.

  • Dow on Track to Wrap Up Worst Month Since March

    U.S. stocks fell Friday, with the Dow Jones Industrial Average on track to close out its worst week and month since March, following a sharp selloff in big technology stocks. The Dow dropped 0.4%, a 95- point decline. It had already shed 5.9% this week, putting it on track for its worst weekly performance since the height of the market tumult.

  • Tech slide, pandemic surge slam Wall Street, biggest weekly loss since March

    U.S. stock indexes closed lower on Friday to cap Wall Street's biggest weekly sell-off since March, as losses in richly priced tech heavyweights, a record rise in coronavirus cases and jitters over the presidential election snuffed investor sentiment.

  • US STOCKS-Wall St set to drop as tech stocks slide, COVID cases jump

    * Twitter slumps as user growth disappoints. * Under Armour (UAA) climbs as revenue forecast exceeds expectations. * Apple (AAPL), Amazon (AMZN), Facebook (FB) drop after results. * Alphabet rises as businesses resume ad spending. * Futures down: Dow 1.12%, S&P 1.05%, Nasdaq 1.34% By Medha Singh and Shivani Kumaresan.

  • EMERGING MARKETS-EMEA FX falls; Turkish lira set for worst month since 2018 crisis

    * Lira set to lose 7.9% in Oct. * MSCI EM stocks index gains in Oct, but outlook dull. * EU GDP awaited. By Ambar Warrick. Turkey's lira led losses across emerging markets in Europe, Middle East and Africa on Friday, and was set for its worst month since the 2018 crisis, weighed by rising coronavirus cases and uncertainty over the U.S. presidential election.

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.